{"id":"https://openalex.org/W7225466473","doi":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","title":"A VALIDATED LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRY/MASS SPECTROMETRY METHOD FOR THE QUANTIFICATION OF UPADACITINIB IN BIOLOGICAL MATRICES: APPLICATION TO PHARMACOKINETICS IN HEALTHY RABBITS","display_name":"A VALIDATED LIQUID CHROMATOGRAPHY-ELECTROSPRAY IONIZATION-MASS SPECTROMETRY/MASS SPECTROMETRY METHOD FOR THE QUANTIFICATION OF UPADACITINIB IN BIOLOGICAL MATRICES: APPLICATION TO PHARMACOKINETICS IN HEALTHY RABBITS","publication_year":2026,"publication_date":"2026-11-07","ids":{"openalex":"https://openalex.org/W7225466473","doi":"https://doi.org/10.22159/ajpcr.2026v19i11.60241"},"language":"en","primary_location":{"id":"doi:10.22159/ajpcr.2026v19i11.60241","doi":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","pdf_url":"https://journals.innovareacademics.in/index.php/ajpcr/article/download/60241/34691","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://journals.innovareacademics.in/index.php/ajpcr/article/download/60241/34691","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017710583","display_name":"Ayesha Begum K","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"AYESHA BEGUM K","raw_affiliation_strings":["Department of Pharmacy, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad, Telangana, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058889850","display_name":"Nagarjuna Rao Mamidipalli","orcid":"https://orcid.org/0000-0002-8408-0313","observed_orcids":["https://orcid.org/0000-0002-8408-0313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"NAGARJUNA RAO MAMIDIPALLI","raw_affiliation_strings":["Department of Pharmacy, Akorn Pharmaceutical Inc., 5 Cedarbrook Dr Cranbury NJ 08512, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Akorn Pharmaceutical Inc., 5 Cedarbrook Dr Cranbury NJ 08512, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161184591","display_name":"VENKATA SOWJANYA THANNERU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"VENKATA SOWJANYA THANNERU","raw_affiliation_strings":["Department of Pharmaceutics, School of Pharmacy, Dr. RVR NRIIT Deemed to be University, Vijayawada (R), Eluru (D), Andhra Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics, School of Pharmacy, Dr. RVR NRIIT Deemed to be University, Vijayawada (R), Eluru (D), Andhra Pradesh, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120860948","display_name":"Ashok Morsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142480","display_name":"Thermo Fisher Scientific (United States)","ror":"https://ror.org/03x1ewr52","country_code":"US","type":"company","lineage":["https://openalex.org/I4210142480"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ASHOK MORSU","raw_affiliation_strings":["Department of Pharmacy, Thermo Fischer Scientific, 3900, Paramount Parkway, Morrisville N.C.27560, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Thermo Fischer Scientific, 3900, Paramount Parkway, Morrisville N.C.27560, United States","institution_ids":["https://openalex.org/I4210142480"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086131713","display_name":"Shankar Cheruku","orcid":"https://orcid.org/0000-0001-7289-8874","observed_orcids":["https://orcid.org/0000-0001-7289-8874"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SHANKAR CHERUKU","raw_affiliation_strings":["Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Viganan\u2019s Foundation for Science, Technology and Research (Deemed to be University), Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Viganan\u2019s Foundation for Science, Technology and Research (Deemed to be University), Hyderabad, Telangana, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"73","last_page":"79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.51419997215271,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.4738999903202057,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9620000123977661},{"id":"https://openalex.org/keywords/rabbits","display_name":"rabbits","score":0.3179999887943268},{"id":"https://openalex.org/keywords/lc-esi-ms-ms-method-validation","display_name":"LC-ESI-MS/MS method validation","score":0.8190000057220459},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.5540000200271606},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7559999823570251},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.7200000286102295}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8686000108718872},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8022000193595886},{"id":"https://openalex.org/C2777379063","wikidata":"https://www.wikidata.org/wiki/Q161233","display_name":"Formic acid","level":2,"score":0.7139999866485596},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.713699996471405},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6535000205039978},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.5509999990463257},{"id":"https://openalex.org/C10390740","wikidata":"https://www.wikidata.org/wiki/Q2282401","display_name":"Analyte","level":2,"score":0.3653999865055084},{"id":"https://openalex.org/C2780092901","wikidata":"https://www.wikidata.org/wiki/Q3433612","display_name":"Correlation coefficient","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3395000100135803},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.33629998564720154},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.3262999951839447},{"id":"https://openalex.org/C64489805","wikidata":"https://www.wikidata.org/wiki/Q873864","display_name":"Liquid chromatography\u2013mass spectrometry","level":3,"score":0.3192000091075897},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.3192000091075897},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.28850001096725464},{"id":"https://openalex.org/C71043704","wikidata":"https://www.wikidata.org/wiki/Q17144692","display_name":"Selected reaction monitoring","level":4,"score":0.27399998903274536},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.26759999990463257},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.2621000111103058}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22159/ajpcr.2026v19i11.60241","doi":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","pdf_url":"https://journals.innovareacademics.in/index.php/ajpcr/article/download/60241/34691","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22159/ajpcr.2026v19i11.60241","doi":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","is_oa":true,"landing_page_url":"https://doi.org/10.22159/ajpcr.2026v19i11.60241","pdf_url":"https://journals.innovareacademics.in/index.php/ajpcr/article/download/60241/34691","source":{"id":"https://openalex.org/S2764968390","display_name":"Asian Journal of Pharmaceutical and Clinical Research","issn_l":"0974-2441","issn":["0974-2441","2455-3891"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":["poland-40"],"host_organization":"https://openalex.org/P4322697801","host_organization_name":"Innovare Academic Sciences","host_organization_lineage":["https://openalex.org/P4322697801"],"host_organization_lineage_names":["Innovare Academic Sciences"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asian Journal of Pharmaceutical and Clinical Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225466473.pdf","grobid_xml":"https://content.openalex.org/works/W7225466473.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1994348463","https://openalex.org/W2041575674","https://openalex.org/W2049606341","https://openalex.org/W2053252244","https://openalex.org/W2087336264","https://openalex.org/W2322517927","https://openalex.org/W2981666147","https://openalex.org/W4295154873","https://openalex.org/W4392657578","https://openalex.org/W7147277295"],"related_works":["https://openalex.org/W4312292856","https://openalex.org/W7219357465","https://openalex.org/W4417239272","https://openalex.org/W3215770882","https://openalex.org/W4401014429","https://openalex.org/W1481647468","https://openalex.org/W3204932495","https://openalex.org/W7220854369","https://openalex.org/W2068685679","https://openalex.org/W2984143136"],"abstract_inverted_index":{"Objectives:":[0],"Quantification":[1],"of":[2,37,48,80,122,127,146,154,174],"upadacitinib":[3],"in":[4,10,177],"biological":[5],"matrices":[6],"using":[7,24],"pharmacokinetic":[8,169],"investigations":[9],"healthy":[11,137,178],"rabbits":[12],"requires":[13],"a":[14,25,33,45,152],"validated":[15],"LC-ESI-MS/MS":[16],"technique.":[17],"Methods:":[18],"The":[19,51,162],"processed":[20],"samples":[21,113],"were":[22,74,104],"separated":[23],"3.5\u00b5m":[26],"symmetric":[27],"C18":[28],"column":[29,56],"(100mm\u00d74.6":[30],"mm)":[31],"with":[32],"mobile":[34],"phase":[35],"consisting":[36],"acetonitrile,":[38],"methanol,":[39],"and":[40,70,83,99,106,117,124,151],"0.1%":[41],"formic":[42],"acid":[43],"at":[44],"volume":[46],"ratio":[47],"50:30:20%":[49],"V/V.":[50],"flow":[52],"rate":[53],"into":[54],"the":[55,68,78,90,100,110,120,128,139,175],"was":[57,165],"adjusted":[58],"to":[59,134,158,168],"0.70":[60],"mL/min.":[61],"Results:":[62],"In":[63,136],"multiple":[64],"reaction":[65],"monitoring":[66],"mode,":[67],"drug":[69,176],"erlotinib":[71],"internal":[72],"standards":[73],"assessed":[75],"by":[76],"watching":[77],"transitions":[79],"m/z":[81,84],"381.3\u219272.08":[82],"394.29\u2192278.19,":[85],"respectively.":[86,108],"Results":[87],"showed":[88],"that":[89],"linearity":[91],"equation":[92],"(y=":[93],"0.00418":[94],"\u00d7":[95],"x":[96],"+":[97],"0.00161)":[98],"correlation":[101],"coefficient":[102],"(R2)":[103],"0.9987":[105],"0.9987,":[107],"For":[109],"quality":[111],"control":[112],"(1.2,":[114],"3.36,":[115],"97.7,":[116],"146.5":[118],"ng/mL),":[119],"%RSD":[121],"intra-":[123],"inter-day":[125],"accuracy":[126],"proposed":[129,163],"approach":[130],"ranged":[131],"from":[132],"2.62":[133],"4.29%.":[135],"rabbits,":[138],"medication":[140],"had":[141],"an":[142],"average":[143],"AUC":[144],"last":[145],"98.379":[147],"\u00b1":[148],"9.845":[149],"h*ng/mL":[150],"Cmax":[153],"54.55":[155],"\u00b14.6ng/mL,":[156],"according":[157],"bioavailability":[159],"studies.":[160],"Conclusion:":[161],"method":[164],"successfully":[166],"applied":[167],"studies":[170],"following":[171],"oral":[172],"administration":[173],"rabbits.":[179]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-08T00:00:00"}